Delphyr

Name: Delphyr
Brand: Delphyr

AI Native

Delphyr is a medical data platform that unlocks patient-level data analytics for busy clinicians.

Est 2024|Valuation $2.7M|Raised $2.6M|6 Ref Customers

LinkedIn 3K|Web traffic 1K|FTEs 9|HQ Amsterdam, Netherlands

Published Oct 7, 2026

01Common complaints

- Company sizes or stages where this product is overkill or insufficient - Solo practitioners or very small clinics that need an immediately deployed, self-serve AI scribe with published pricing may find a demo-led, integration-focused sales model unsuitable. - Industries or use cases where competitors are clearly superior - U.S. health systems standardized on Epic/Cerner that require vendors to demonstrate extensive enterprise-scale Epic/Cerner integration references may prefer vendors with those established enterprise footprints (for example, ambient-scribe vendors with broad enterprise references). - UK NHS buyers whose procurement and governance needs are tightly coupled to DTAC/MHRA pathways may prioritize vendors with established NHS procurement experience. - Technical requirements that this product cannot meet - If a buyer requires confirmed native integration with bidirectional structured writeback into specific EHR fields, they should verify Delphyr's integration depth for the target EHR before selecting the product. - Organizations requiring HIPAA BAAs and U.S. data residency should verify suitability; the vendor's publicly stated posture emphasizes European processing. - Budget constraints that make alternatives more appropriate - Buyers needing published, predictable pricing should consider vendors that publish per-user plans or self-serve options. - Specific workflows or integrations where the product falls short - If the primary need is only ambient transcription and templated note drafting without deeper retrieval/summary needs, simpler embedded or extension-based alternatives may be more appropriate; in Bricks specifically, Noteless provides browser-extension-based SOAP note drafting that overlaps with certain workflows. - Red flags in the buying process - Certification statuses presented as "in progress" without clear timelines, certificate scope, or independent evidence - Lack of published security documentation (SSO/SCIM, audit logs, encryption details) to support early-stage procurement evaluations - Current limitations acknowledged by the vendor - MDR certification is presented as "in progress" in vendor materials. This indicates a current regulatory process rather than a completed certification (public status should be verified at contract time). - Features on the roadmap (not yet available) - note estimated dates if available - MDR certification expectations are referenced in vendor content; buyers should verify the current status and timelines at the point of evaluation. - Scale limitations (at what volume/size does it break down?) - No public documentation of scale limits or performance degradation by volume was identified. - Security or compliance gaps - Publicly verifiable proof of SOC 2 Type II or ISO certificate identifiers and the scope of audits was not found in the materials reviewed. - Technical debt or architectural limitations mentioned in reviews - No independent reviews were located that discuss technical debt or architecture constraints. - API limitations or integration constraints - The vendor emphasizes integration-first deployment, but public materials do not provide a comprehensive list of supported EHRs, standards compliance (FHIR/HL7) details, or specific writeback capabilities; buyers should request integration specifications and reference implementations.

Deal disqualifiers: what makes a POOR fit

Organizations that require publicly verifiable third-party security certification documentation and extensive security artifacts before evaluation
Environments where the EHR cannot support the vendor's preferred embedding approach or where integration resources are not available
Buyers who require published pricing or self-serve trials to start evaluation

Why some customers left for competitors (churn reasons)

No independent churn narratives or exit reasons were found in the sources reviewed.

02Why they buy

- Competitive advantages validated by customer feedback (not just vendor claims) - Independent customer feedback on major review platforms was not located; visible validation consists mainly of partner statements and press coverage rather than independent reviews. - Unique features and capabilities competitors lack - The vendor emphasizes an embedded retrieval-and-summarization approach that cites underlying patient-record elements and links to guidelines. If implemented as described, this can differentiate the product relative to tools that focus solely on ambient transcription. - Similar grounded/ retrieval-augmented approaches are increasingly common; differentiation among vendors typically depends on integration depth, safety workflows, and governance. - Differentiation from competitors based on reviews - No independent review-based differentiation was found in the sources reviewed. - Value propositions with evidence from case studies - Available case material is vendor-published and partner-provided; independent verification of quantitative benefits was not found. - Areas where competitors clearly have advantages (be balanced) - Competitors with established enterprise footprints may provide more public case studies with measurable outcomes, clearer EHR integration lists, and broader third-party review presence.

03Field reports

Direct quotes from mainstream review platforms

Gartner Peer Insights: no accessible Delphyr product listing or reviews were found in searches of that platform.
G2: no Delphyr listing found; search results returned name collisions (e.g., "Delpha") that are unrelated.
TrustRadius: no Delphyr listing found in accessible searches.
Reddit / HackerNews: no substantive Delphyr-specific discussion threads were located in the searches performed.

Vendor / partner testimonials (vendor-provided content)

Tetra / Bricks (partner testimonial): a Tetra co-founder described the Delphyr integration as completed within a short period and expressed early interest from users in exploring additional capabilities. This is partner-provided content and should be treated as vendor/partner marketing rather than an independent review.
A Dutch Endometriosis Clinic quote appears on vendor pages and social channels; this is vendor-provided testimonial content.

Availability of balanced star-rating reviews

Independent star-rating reviews on major review platforms for Delphyr were not found in accessible sources. Therefore, a balanced comparison of high-rated vs low-rated reviews on established platforms could not be constructed from the sources reviewed.

Common criticisms and complaints (support issues, bugs, missing features)

Independent criticisms specific to Delphyr were not located in public third-party review sources. Where independent feedback is absent, criticism in this report is inferred by referencing typical category risks (see "Critical Analysis & Common Complaints").

Reasons customers chose this product (based on vendor positioning)

Based on vendor statements, reasons cited include embedding functionality in existing EHR workflows, a Europe-focused data residency posture, and combined retrieval/summarization with guideline retrieval capabilities.

Specific outcomes customers achieved (with metrics when available)

Vendor-published claims reference substantial time-savings in certain administrative tasks. These metrics are vendor-published and lack disclosed methodology, baselines, sample sizes, or independent validation.

Deal-breakers and reasons customers didn't purchase

Not identified in independent sources.

Detailed customer success stories with metrics

Tetra/Bricks integration
- The vendor describes Delphyr deployed within Bricks for primary care (announced in 2026).
- Functionality listed in vendor materials: patient-data search, consult-preparation summaries, and letter drafting.
- The vendor notes that a number of GP practices in the Bricks ecosystem have begun use, but no named practices, usage volumes, pre/post metrics, or study design details were provided publicly.

Specific results and quantified business impact

Vendor materials include time-savings claims (for example, claims of substantial reductions in time spent on certain tasks). These results are vendor-published and are not independently validated in the public sources accessed.

Implementation details and time to value

A partner testimonial states that the integration with the partner environment was completed within a short timeframe. This likely reflects a specific partnership integration and may not generalize to all EHR environments.

Challenges faced during adoption and how they were resolved

No detailed public accounts of adoption challenges or remediation steps were identified.

CRITICAL: Note when metrics are vendor-published without independent verification

All outcome metrics identified in the sources accessed are vendor-published and should be treated as directional marketing claims until independently validated.

Include mixed results - projects that struggled or failed when available

No public accounts of unsuccessful pilots or failed deployments were identified.

04Best fit

Company sizes: specific employee counts and revenue ranges

Likely ICP (inferred from demo-led sales and integration-focused posture):
- Mid-market to enterprise healthcare organizations and EHR vendors
- Examples: hospitals and health networks (large organizations) or multi-practice primary care groups (small-to-mid sized practices) using supported HIS/EHR platforms

Industries and verticals where adoption is strongest (with customer examples)

Primary care in the Netherlands (via the Bricks/Tetra ecosystem) is explicitly referenced in vendor materials.
Hospitals and mental healthcare providers are vendor-stated target segments.

Roles and personas: decision makers AND end users

Decision makers:
- CMIO / Chief Medical (Data) Officer
- CIO / CISO / Data Protection Officer
- Clinical operations leadership
- EHR product leadership (when sold via EHR vendor partnership)
End users:
- Physicians, nurses, medical assistants

Pain points and challenges the product addresses

Retrieving key patient information from fragmented longitudinal records
Reducing administrative time for summaries, consult preparation, and correspondence drafting
Bringing guideline and literature support closer to the point of care

Qualification criteria: what makes a GREAT fit

Requirement to keep workflows inside the existing clinical system interface
EU data residency requirement or preference
High volumes of unstructured clinical notes where retrieval and summarization can yield productivity gains

Real customer examples with company names when available

Tetra / Bricks (EHR vendor partnership)
Dutch Endometriosis Clinic (vendor-provided testimonial context)

05The pitch

What the product does (core value proposition in objective terms)

- Delphyr is an AI platform for healthcare designed to operate within existing clinical systems/EHR workflows. - Core workflows described on the vendor site include: - Search and summarization across patient record artifacts (labs, notes, imaging, medications, correspondence) into a consolidated, clinically relevant view - Access to evidence‑based guidance (guidelines and literature retrieval) - Ambient listening to support documentation - Workflow automation to reduce administrative tasks - The vendor positions the product as an embedded AI layer rather than a replacement EHR user interface (vendor marketing phrasing).

Target market and market positioning

- Target users: healthcare professionals (physicians, nurses, clinical teams), with solution pages that reference: - Primary care - Hospitals - Mental healthcare - Positioning summary (vendor language restated in neutral terms): - An integration‑focused clinical AI intended to embed into the EHR to reduce time spent searching and summarizing and to support clinical decision‑making. - A Europe‑focused privacy and compliance posture: the vendor states that data is processed within Europe and references MDR certification as being in progress.

Get a comprehensive analysis of Delphyr including market position, competitive landscape, adoption trends, and peer benchmarks.

Download full report →